REQUEST A DEMO
Total
USD $0.00
Search more companies

Imbiodent Colombia S A S (Colombia)

Main Activities: Pharmacies and Drug Stores
Full name: Imbiodent Colombia S A S Profile Updated: April 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Imbiodent Colombia S A S is based in Colombia, with the head office in Bogota D.C.. The enterprise operates in the Pharmacies and Drug Stores industry. The enterprise was incorporated on January 18, 2013. It currently has a total number of 13 (2024) employees. From the latest financial highlights, Imbiodent Colombia S A S reported a net sales revenue increase of 60.55% in 2023. Its total assets grew by 93.54% over the same period. In 2023, Imbiodent Colombia S A S’s net profit margin increased by 2.48%.

Headquarters
Cr 13 # 94A - 25 Of 501
Bogota D.C.; Bogota D.C; Postal Code: 0809

Contact Details: Purchase the Imbiodent Colombia S A S report to view the information.

Basic Information
Total Employees:
Purchase the Imbiodent Colombia S A S report to view the information.
Outstanding Shares:
Purchase the Imbiodent Colombia S A S report to view the information.
Incorporation Date:
January 18, 2013
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Company Performance
Financial values in the chart are available after Imbiodent Colombia S A S report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
60.55%
Total operating revenue
60.55%
Operating profit (EBIT)
127.13%
Net Profit (Loss) for the Period
437.59%
Total assets
93.54%
Total equity
16.74%
Operating Profit Margin (ROS)
0.67%
Net Profit Margin
2.48%
Return on Equity (ROE)
21.22%
Quick Ratio
-0.24%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?